Suchergebnisse - "Tiraboschi, Juan M"

PubPharm (15)

1

Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von de Lazzari, E. | Negredo, E. | Domingo, P. | +12

2

Dynamics of the Decay of Human Immunodeficiency Virus (HIV) RNA and Distribution of Bictegravir in the Genital Tract and Rectum in Antiretroviral-naive Adults Living With HIV-1 Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (Spanish HIV/AIDS Research Network, PreEC/RIS 58)

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Imaz, A. | Tiraboschi, J. | Niubó, J. | +14

3

No Changes in Human Immunodeficiency Virus (HIV) Suppression and Inflammatory Markers in Cerebrospinal Fluid in Patients Randomly Switched to Dolutegravir Plus Lamivudine (Spanish HIV/AIDS Research Network, PreEC/RIS 62)

enthalten in: The Journal of infectious diseases | 2021

von Tiraboschi, J. | Rojas, J. | Zetterberg, H. | +10

4

Seminal Tenofovir Concentrations, Viral Suppression, and Semen Quality With Tenofovir Alafenamide, Compared With Tenofovir Disoproxil Fumarate (Spanish HIV/AIDS Research Network, PreEC/RIS 40)

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2019

von Imaz, A. | Niubó, J. | Cottrell, M. | +6

5

Cerebrospinal fluid drug concentrations and viral suppression in HIV-1-infected patients receiving ritonavir-boosted atazanavir plus lamivudine dual antiretroviral therapy (Spanish HIV/AIDS Research Network, PreEC/RIS 39)

enthalten in: Journal of neurovirology | 2018

von Imaz, A. | Niubó, J. | Amara, A. | +7

6

Cerebrospinal fluid drug concentrations and viral suppression in HIV-1-infected patients receiving ritonavir-boosted atazanavir plus lamivudine dual antiretroviral therapy (Spanish HIV/AIDS Research Network, PreEC/RIS 39)

enthalten in: Journal of neurovirology | 2018

von Imaz, A. | Niubó, J. | Amara, A. | +7

7

Cerebrospinal fluid drug concentrations and viral suppression in HIV-1-infected patients receiving ritonavir-boosted atazanavir plus lamivudine dual antiretroviral therapy (Spanish HIV/AIDS Research Network, PreEC/RIS 39)

enthalten in: Journal of neurovirology | 2018

von Imaz, A. | Niubó, J. | Amara, A. | +7

8

Atherogenic properties of LDL particles after switching from Truvada or Kivexa plus lopinavir/r to lamivudine plus lopinavir/r : OLE-MET substudy

enthalten in: HIV clinical trials | 2017

von Saumoy, M. | Tiraboschi, J. | Ordoñez-Llanos, J. | +6

9

Atherogenic properties of LDL particles after switching from Truvada or Kivexa plus lopinavir/r to lamivudine plus lopinavir/r: OLE-MET substudy

enthalten in: HIV clinical trials | 2017

von Saumoy, M. | Tiraboschi, J. | Ordoñez-Llanos, J. | +6

10

Brief Report : Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure Prophylaxis

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2016

von Fox, J. | Tiraboschi, J. | Herrera, C. | +9